- Summary
- provides method of treating and imaging EBV-associated cancers.
- Technology Benefits
- Treating and imaging EBV-associated cancers
- Technology Application
- detection diagnosis
- Detailed Technology Description
- This invention provides a nucleus-permeable small-molecule inhibitor, L2P4 (where L2 is 4-(4-(Diethylamino)styryl)-N-carboxymethylpyridinium chloride and P4 is an amino acid sequence comprising CAhxYFMVFGGRrRK and they were coupled through amide bond) and synthesis thereof, which effectively targets the dimerization interface of EBNA1, a critical process for the growth of EBVs and the associated tumors. The present invention also provides method of treating and imaging EBV-associated cancers.
- Type of Cooperation
- Licensing
- Publication Country/ Region
- US
- Application Date
- 24/04/2017 00:00:00
- Application No.
- 15/495,971
- Patent Information
- A61K/51/00
- Others
- CN, TW, EP
- Country/Region
- Hong Kong
|
